Cargando…

Individual participant data meta-analysis of prognostic factor studies: state of the art?

BACKGROUND: Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abo-Zaid, Ghada, Sauerbrei, Willi, Riley, Richard D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413577/
https://www.ncbi.nlm.nih.gov/pubmed/22530717
http://dx.doi.org/10.1186/1471-2288-12-56
_version_ 1782240081919082496
author Abo-Zaid, Ghada
Sauerbrei, Willi
Riley, Richard D
author_facet Abo-Zaid, Ghada
Sauerbrei, Willi
Riley, Richard D
author_sort Abo-Zaid, Ghada
collection PubMed
description BACKGROUND: Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthesising prognostic factor studies. We assessed the feasibility and conduct of this approach. METHODS: A systematic review to identify published IPD meta-analyses of prognostic factors studies, followed by detailed assessment of a random sample of 20 articles published from 2006. Six of these 20 articles were from the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in traumatic brain injury) collaboration, for which additional information was also used from simultaneously published companion papers. RESULTS: Forty-eight published IPD meta-analyses of prognostic factors were identified up to March 2009. Only three were published before 2000 but thereafter a median of four articles exist per year, with traumatic brain injury the most active research field. Availability of IPD offered many advantages, such as checking modelling assumptions; analysing variables on their continuous scale with the possibility of assessing for non-linear relationships; and obtaining results adjusted for other variables. However, researchers also faced many challenges, such as large cost and time required to obtain and clean IPD; unavailable IPD for some studies; different sets of prognostic factors in each study; and variability in study methods of measurement. The IMPACT initiative is a leading example, and had generally strong design, methodological and statistical standards. Elsewhere, standards are not always as high and improvements in the conduct of IPD meta-analyses of prognostic factor studies are often needed; in particular, continuous variables are often categorised without reason; publication bias and availability bias are rarely examined; and important methodological details and summary results are often inadequately reported. CONCLUSIONS: IPD meta-analyses of prognostic factors are achievable and offer many advantages, as displayed most expertly by the IMPACT initiative. However such projects face numerous logistical and methodological obstacles, and their conduct and reporting can often be substantially improved.
format Online
Article
Text
id pubmed-3413577
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34135772012-08-08 Individual participant data meta-analysis of prognostic factor studies: state of the art? Abo-Zaid, Ghada Sauerbrei, Willi Riley, Richard D BMC Med Res Methodol Research Article BACKGROUND: Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthesising prognostic factor studies. We assessed the feasibility and conduct of this approach. METHODS: A systematic review to identify published IPD meta-analyses of prognostic factors studies, followed by detailed assessment of a random sample of 20 articles published from 2006. Six of these 20 articles were from the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in traumatic brain injury) collaboration, for which additional information was also used from simultaneously published companion papers. RESULTS: Forty-eight published IPD meta-analyses of prognostic factors were identified up to March 2009. Only three were published before 2000 but thereafter a median of four articles exist per year, with traumatic brain injury the most active research field. Availability of IPD offered many advantages, such as checking modelling assumptions; analysing variables on their continuous scale with the possibility of assessing for non-linear relationships; and obtaining results adjusted for other variables. However, researchers also faced many challenges, such as large cost and time required to obtain and clean IPD; unavailable IPD for some studies; different sets of prognostic factors in each study; and variability in study methods of measurement. The IMPACT initiative is a leading example, and had generally strong design, methodological and statistical standards. Elsewhere, standards are not always as high and improvements in the conduct of IPD meta-analyses of prognostic factor studies are often needed; in particular, continuous variables are often categorised without reason; publication bias and availability bias are rarely examined; and important methodological details and summary results are often inadequately reported. CONCLUSIONS: IPD meta-analyses of prognostic factors are achievable and offer many advantages, as displayed most expertly by the IMPACT initiative. However such projects face numerous logistical and methodological obstacles, and their conduct and reporting can often be substantially improved. BioMed Central 2012-04-24 /pmc/articles/PMC3413577/ /pubmed/22530717 http://dx.doi.org/10.1186/1471-2288-12-56 Text en Copyright ©2012 Abo-Zaid et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abo-Zaid, Ghada
Sauerbrei, Willi
Riley, Richard D
Individual participant data meta-analysis of prognostic factor studies: state of the art?
title Individual participant data meta-analysis of prognostic factor studies: state of the art?
title_full Individual participant data meta-analysis of prognostic factor studies: state of the art?
title_fullStr Individual participant data meta-analysis of prognostic factor studies: state of the art?
title_full_unstemmed Individual participant data meta-analysis of prognostic factor studies: state of the art?
title_short Individual participant data meta-analysis of prognostic factor studies: state of the art?
title_sort individual participant data meta-analysis of prognostic factor studies: state of the art?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413577/
https://www.ncbi.nlm.nih.gov/pubmed/22530717
http://dx.doi.org/10.1186/1471-2288-12-56
work_keys_str_mv AT abozaidghada individualparticipantdatametaanalysisofprognosticfactorstudiesstateoftheart
AT sauerbreiwilli individualparticipantdatametaanalysisofprognosticfactorstudiesstateoftheart
AT rileyrichardd individualparticipantdatametaanalysisofprognosticfactorstudiesstateoftheart